Stock Track | OPKO Health Plummets 5.14% Following Jefferies Downgrade and Price Target Cut

Stock Track

Nov 01

OPKO Health (OPK) shares tumbled 5.14% in intraday trading on Friday, as investors reacted to a significant downgrade from a major Wall Street firm. The biotechnology and diagnostics company's stock faced pressure after Jefferies lowered its rating and slashed its price target, signaling potential challenges ahead for the company.

Jefferies, a prominent investment bank and financial services company, downgraded OPKO Health from Buy to Hold, reflecting a more cautious stance on the stock's prospects. Additionally, the firm reduced its price target for OPKO Health to $1.60 from the previous $2.00, representing a 20% cut in their valuation outlook.

The downgrade and price target reduction appear to have sparked concern among investors, leading to the significant sell-off in OPKO Health's shares. As the market digests this new analyst perspective, it remains to be seen how OPKO Health will address these concerns and potentially regain investor confidence in the near term.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1108806192"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1108806192\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1108806192?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-01 01:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1108806192","market":"hk","top_or_hot":-1,"title":"Stock Track | OPKO Health Plummets 5.14% Following Jefferies Downgrade and Price Target Cut","media":"Stock Track","content":"<p>OPKO Health (OPK) shares tumbled 5.14% in intraday trading on Friday, as investors reacted to a significant downgrade from a major Wall Street firm. The biotechnology and diagnostics company's stock faced pressure after Jefferies lowered its rating and slashed its price target, signaling potential challenges ahead for the company.</p>\n\n<p>Jefferies, a prominent investment bank and financial services company, downgraded OPKO Health from Buy to Hold, reflecting a more cautious stance on the stock's prospects. Additionally, the firm reduced its price target for OPKO Health to $1.60 from the previous $2.00, representing a 20% cut in their valuation outlook.</p>\n\n<p>The downgrade and price target reduction appear to have sparked concern among investors, leading to the significant sell-off in OPKO Health's shares. As the market digests this new analyst perspective, it remains to be seen how OPKO Health will address these concerns and potentially regain investor confidence in the near term.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | OPKO Health Plummets 5.14% Following Jefferies Downgrade and Price Target Cut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | OPKO Health Plummets 5.14% Following Jefferies Downgrade and Price Target Cut\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-01 01:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>OPKO Health (OPK) shares tumbled 5.14% in intraday trading on Friday, as investors reacted to a significant downgrade from a major Wall Street firm. The biotechnology and diagnostics company's stock faced pressure after Jefferies lowered its rating and slashed its price target, signaling potential challenges ahead for the company.</p>\n\n<p>Jefferies, a prominent investment bank and financial services company, downgraded OPKO Health from Buy to Hold, reflecting a more cautious stance on the stock's prospects. Additionally, the firm reduced its price target for OPKO Health to $1.60 from the previous $2.00, representing a 20% cut in their valuation outlook.</p>\n\n<p>The downgrade and price target reduction appear to have sparked concern among investors, leading to the significant sell-off in OPKO Health's shares. As the market digests this new analyst perspective, it remains to be seen how OPKO Health will address these concerns and potentially regain investor confidence in the near term.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OPK","symbol_name":"Opko Health","start_time":0,"source_url":"","article_id":"1108806192","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1108806192","pubTimestamp":1761930603,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"OPKO Health (OPK) shares tumbled 5.14% in intraday trading on Friday, as investors reacted to a significant downgrade from a major Wall Street firm. The biotechnology and diagnostics company's stock...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OPK":"Opko Health"},"translate_title":"个股追踪|Jefferies下调评级和目标价下调后，OPKO Health暴跌5.14%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OPK":1},"content_text":"OPKO Health (OPK) shares tumbled 5.14% in intraday trading on Friday, as investors reacted to a significant downgrade from a major Wall Street firm. The biotechnology and diagnostics company's stock faced pressure after Jefferies lowered its rating and slashed its price target, signaling potential challenges ahead for the company.\nJefferies, a prominent investment bank and financial services company, downgraded OPKO Health from Buy to Hold, reflecting a more cautious stance on the stock's prospects. Additionally, the firm reduced its price target for OPKO Health to $1.60 from the previous $2.00, representing a 20% cut in their valuation outlook.\nThe downgrade and price target reduction appear to have sparked concern among investors, leading to the significant sell-off in OPKO Health's shares. As the market digests this new analyst perspective, it remains to be seen how OPKO Health will address these concerns and potentially regain investor confidence in the near term.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}